We found 2 drugmaker programs for Eosinophilic Granulomatosis with Polyangiitis medicines and 2 charity funds (1 open at our last check). Tell us your insurance below and we'll show what to try first.
Help for Eosinophilic Granulomatosis with Polyangiitis depends mostly on how you're covered. Pick the one that sounds like you. We'll name the funds and programs that fit, and what won't work, so you don't waste a phone call.
Independent foundations pay copays, coinsurance and sometimes insurance premiums for people who already have coverage. Funds open and close as donations come in, so each one shows what the foundation said on the date we checked.
Covers: Copays, premiums or other treatment costs.
Covers: Out-of-pocket costs for approved medications. Up to $7,400 a year.
Copay cards lower what people with private insurance pay. Federal rules bar them for Medicare, Medicaid and TRICARE. Free medicine programs are for people without enough coverage and usually have income limits. We read each program on the drugmaker's own site.
Eligible commercially insured patients may pay as little as $0 for FASENRA and its administration, up to $13,000 per calendar year. Not for government insurance.
The savings program also covers the cost of injection administration (not office visits), within the same $13,000 yearly limit.
AstraZeneca's AZ&Me program provides FASENRA at no cost to eligible people without insurance or on Medicare who cannot afford it.
FASENRA 360 Patient Navigators answer questions about insurance coverage and out-of-pocket costs; nurse support available.
Free drug is through AZ&Me (1-800-292-6363, azandmeapp.com); income limits apply. Medicare patients enrolled in AZ&Me must re-enroll for 2027.
For eligible commercially insured patients, the program pays out-of-pocket costs above $25 per dose, up to $8,000 per calendar year.
GSK Patient Assistance Program may provide NUCALA at no cost to uninsured or Medicare patients who meet income and other requirements.
Patient Navigators check insurance coverage, explain costs and help with copay program applications. Mon-Fri 8AM-8PM ET.
Copay program excludes uninsured patients and Medicare, Medicare Advantage, Part D, Medicaid, Medigap, VA, DoD and TRICARE; copay program line 1-800-691-1939. Free-drug program is run by the separate GSK Patient Access Programs Foundation.
Most of these programs start with one call, and having these ready makes it shorter. Tick them off as you go. Nothing here is saved or sent anywhere.
Call the drugmaker's support line first. Its case managers check your benefits and often fill out forms with your doctor. If a charity fund is closed, sign up on the foundation's page to hear when it reopens. Most programs need renewing every year, and many copay cards reset in January.
Yes. Trial Friend lists 2 drugmaker programs for Eosinophilic Granulomatosis with Polyangiitis medicines and 2 charity funds, 1 of them open at our last check. We checked every one at the source on or before October 19, 2026. Which ones fit depends on your insurance. Copay cards are for people with private insurance, charity funds usually need some insurance, and free medicine programs are for people without enough coverage.
No. Federal rules bar drugmaker copay cards for drugs paid by Medicare, Medicaid or TRICARE. For Eosinophilic Granulomatosis with Polyangiitis, 0 charity funds on this page accept Medicare, and 2 drugmaker free medicine programs name Medicare patients among those who may qualify. In 2026, Medicare Part D also caps yearly out-of-pocket costs for covered drugs at $2,100.
At our last check, HealthWell Foundation's ANCA-Associated Vasculitis and Granulomatosis with Polyangiitis fund was open to new applicants. Funds open and close as donations come in, so check the foundation's page before you apply.
Of the drugmaker programs for Eosinophilic Granulomatosis with Polyangiitis medicines, 2 offer free medicine to people without insurance who qualify, usually with income limits. Most charity funds pay copays and premiums, so they need some insurance. The drugmaker's support line can also check whether you qualify for coverage you don't have yet.
How we check: drugmaker programs come only from each drugmaker's own pages. Fund status is copied from each foundation's list (HealthWell Foundation, TotalAssist) on the date shown. Programs change, so confirm with the program before you rely on it. Trial Friend shares information, not financial, legal or medical advice, and each program decides who qualifies. See something wrong? Email jason@trialfriend.com.
